AQST - Aquestive Therapeutics reports Q1 results raises FY 2023 revenue guidance
2023-05-02 17:11:24 ET
- Aquestive Therapeutics press release ( NASDAQ: AQST ): Q1 GAAP EPS of $0.11.
- Revenue of $11.13M (-9.3% Y/Y) beats by $1.19M .
- Now sees FY 2023 revenue of $42M to $46M from $37M to $41M previously. The consensus estimate is $39.06M.
For further details see:
Aquestive Therapeutics reports Q1 results, raises FY 2023 revenue guidance